VISTAGEN THERAPEUTICS, INC. Lease Obligation Incurred
VISTAGEN THERAPEUTICS, INC. (VTGN) reported Lease Obligation Incurred of $139.70 thousand for the 184-month period ending 2014-03-31, per its 10-K filed 2014-06-25.
Discontinued › Cash Flow › Other Cash Flow Items
us-gaap:CapitalLeaseObligationsIncurred · last filed 2014-06-25
- VISTAGEN THERAPEUTICS, INC. lease obligation incurred for fiscal 2012 was $19.00K.
| Period end | Lease Obligation Incurred 12 month | Lease Obligation Incurred 166 month | Lease Obligation Incurred 178 month | Lease Obligation Incurred 184 month |
|---|---|---|---|---|
| 2014-03-31 | $139.70K 10-K · filed 2014-06-25 | |||
| 2013-03-31 | $139.70K 10-K · filed 2013-07-18 | |||
| 2012-03-31 | $19.00K 10-K · filed 2013-07-18 | $139.70K 10-K · filed 2012-07-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B |